N-Boc-3,4-dihydro-2H-pyridine - CAS 131667-57-7
Catalog: |
BB007466 |
Product Name: |
N-Boc-3,4-dihydro-2H-pyridine |
CAS: |
131667-57-7 |
Synonyms: |
tert-butyl 3,4-dihydro-2H-pyridine-1-carboxylate |
IUPAC Name: | tert-butyl 3,4-dihydro-2H-pyridine-1-carboxylate |
Description: | N-Boc-3,4-dihydro-2H-pyridine (CAS# 131667-57-7) is a useful research chemical. |
Molecular Weight: | 183.25 |
Molecular Formula: | C10H17NO2 |
Canonical SMILES: | CC(C)(C)OC(=O)N1CCCC=C1 |
InChI: | InChI=1S/C10H17NO2/c1-10(2,3)13-9(12)11-7-5-4-6-8-11/h5,7H,4,6,8H2,1-3H3 |
InChI Key: | VIBQTJLMJANION-UHFFFAOYSA-N |
Boiling Point: | 254 °C |
Purity: | > 98 % |
Density: | 1.029 g/cm3 |
Storage: | Inert atmosphere, 2-8 °C |
LogP: | 2.46890 |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P273, P301+P310, P321, P330, P391, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
BR-112020026450-A2 | COMPOUNDS OF FORMULA I | 20180629 |
BR-112019025740-A2 | COMPOUNDS TO TREAT HUNTINGTON'S DISEASE | 20170605 |
BR-112019015314-A2 | compounds to inhibit lrrk2 kinase activity | 20170125 |
JP-2019534252-A | Tetrahydropyridine derivatives and their use as antibacterial agents | 20160928 |
CN-110325533-A | The inhibitor of MENIN-MLL interaction | 20160916 |
Complexity: | 216 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 183.125928785 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 183.125928785 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 29.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyridines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS